Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data-Reference-Cited by-同舟云学术

Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data

Published:2008-12 Issue:6 Volume:33 Page:677-684
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:

Author:

Fukuhara K.,Ikawa K.,Morikawa N.,Kumagai K.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.2008.00966.x/fullpdf

Reference26 articles.

1. Methotrexate toxicity: correlation with duration of administration: plasma levels, dose and excretion pattern;Goldie;European Journal of Cancer,1972

2. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity;Stoller;New England Journal of Medicine,1977

3. Pharmacokinetic monitoring of high-dose methotrexate: early recognition of high-risk patients;Evans;Cancer Chemotherapy and Pharmacology,1979

4. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate;Masson;Journal of Clinical Investigation,1996

5. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect;Evans;New England Journal of Medicine,1986

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma;Cancer Chemotherapy and Pharmacology;2024-08-24

2. A gold-based multiplex immunochromatographic sensor for detecting paclitaxel, methotrexate, and 5-fluorouracil in clinical samples;Nano Research;2024-04-06

3. Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies;European Journal of Clinical Pharmacology;2024-02-12

4. External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors;The Journal of Clinical Pharmacology;2024-01-11

5. A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis;Biomedicine & Pharmacotherapy;2023-12